Clinical Trial Update: An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) [Phase 4]

View source ↗

Summary

Phase 4 exploratory study evaluating multiple doses of omalizumab in cystic fibrosis patients with allergic bronchopulmonary aspergillosis; the trial was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis
• Cystic Fibrosis

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cystic Fibrosis, Allergic Bronchopulmonary Aspergillosis | Phase 4 | Status: TERMINATED | Results posted: 2011-08-04